KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cronos (CRON) Cash & Equivalents (2016 - 2026)

Cronos has reported Cash & Equivalents over the past 11 years, most recently at $821.9 million for Q1 2026.

  • For Q1 2026, Cash & Equivalents rose 3.01% year-over-year to $821.9 million; the TTM value through Mar 2026 reached $821.9 million, up 3.01%, while the annual FY2025 figure was $791.8 million, 7.8% down from the prior year.
  • Cash & Equivalents for Q1 2026 was $821.9 million at Cronos, up from $791.8 million in the prior quarter.
  • Over five years, Cash & Equivalents peaked at $862.0 million in Q3 2024 and troughed at $409.4 million in Q2 2023.
  • A 5-year average of $736.9 million and a median of $791.8 million in 2025 define the central range for Cash & Equivalents.
  • Biggest five-year swings in Cash & Equivalents: tumbled 51.98% in 2023 and later surged 107.16% in 2024.
  • Year by year, Cash & Equivalents stood at $764.6 million in 2022, then decreased by 12.47% to $669.3 million in 2023, then grew by 28.32% to $858.8 million in 2024, then dropped by 7.8% to $791.8 million in 2025, then rose by 3.8% to $821.9 million in 2026.
  • Business Quant data shows Cash & Equivalents for CRON at $821.9 million in Q1 2026, $791.8 million in Q4 2025, and $784.2 million in Q3 2025.